文章摘要
王晓露1 解方为2 陈曦2 张霞2 欧阳学农2.丹参酮IIA 对大鼠移植性肝癌的抑制作用[J].,2011,11(11):2062-2064
丹参酮IIA 对大鼠移植性肝癌的抑制作用
The Inhibitive Effect of Tanshinone IIA on Implanted Hepatoma in Rats
  
DOI:
中文关键词: 丹参酮IIA  HMGB1  VEGF
英文关键词: Tanshinone IIA  HMGB1  VEGF
基金项目:" 十一五" 军队中医药研发推广专项课题基金资助(2006051002)
作者单位
王晓露1 解方为2 陈曦2 张霞2 欧阳学农2 南京军区福州总医院肿瘤科 
摘要点击次数: 601
全文下载次数: 867
中文摘要:
      目的:观察丹参酮IIA 对大鼠移植性肝癌的抑制作用。方法:将SD 大鼠随机分为假手术组、模型组、丹参酮IIA 高、低剂量 组。各组动物于移植术后12d 处死。分离肿瘤测量其体积,realtime RT-PCR 法和western blot 法检测肿瘤组织中HMGB1、VEGF mRNA 和蛋白的表达。结果:丹参酮IIA 能明显降低肿瘤体积,降低肿瘤组织中HMGB1、VEGF mRNA 和蛋白的表达。结论:丹参 酮IIA 能抑制大鼠移植性肝癌的生长,其机制可能与抑制HMGB1、VEGF 表达有关。
英文摘要:
      Objective: To study the effect of Tanshinone IIA on implanted hepatoma in rats. Method: Sprague Dawley rats were divide into normal group, sham operated group and two Tanshinone IIA groups. Contents of HMGB1, VEGF protein and mRNA were detected by immunohistochemical and real-time PCR methods, respectivly. Result: In Tanshinone IIA groups, Contents of HMGB1, VEGF protein and mRNA were decreased markedly. Conclusion: Tanshinone IIA could inhibit the implanted hepatoma in rats. This maybe be concerned with that it could inhibit the expression of HMGB1 and VEGF in the implanted hepatoma in rats.
查看全文   查看/发表评论  下载PDF阅读器
关闭